Radar on Drug Benefits

News Briefs

✦ The FDA on Dec. 18 issued an emergency use authorization for Moderna, Inc.’s vaccine for preventing COVID-19, making it the second vaccine to receive an EUA. The Moderna vaccine’s EUA allows it to be distrib...
0 Comments
© 2025 MMIT

Hy-Vee’s New PBM Will Likely Need a Niche to Compete

Midwestern supermarket chain Hy-Vee, Inc. launched a new PBM subsidiary on Dec. 3, joining the already-crowded ranks of retail stores that have done the same, such as Costco Wholesale Corp., The Kroger Co. and Walgr...
0 Comments
© 2025 MMIT

Plans Step Up Use of Pharmacists in Direct Care, Data Analysis

Multiple insurers are increasing their use of pharmacists — both those they employ and pharmacists in retail settings — to help deliver care to hard-to-reach members who are at risk of poor health outcomes. T...
0 Comments
© 2025 MMIT

Medicaid Programs Face Gene and Cell Therapy ‘Hurricane’

Though cutting-edge gene and cell therapies can transform patients’ lives, they’ve strained pharmacy budgets across the health care sector, and state Medicaid programs are no exception. With dozens of such thera...
0 Comments
© 2025 MMIT

Specialty Drug Spending Continues to Rise, Driven by Higher Utilization

Per-member per-year (PMPY) specialty drug spending rose 13.6% from 2018 to 2019, according to Pharmaceutical Strategies Group’s annual report, which analyzed 45 million pharmacy claims and 54 million medical claim...
0 Comments
© 2025 MMIT

Oral Alternatives to Injectables Still Face Stiff Competition

In its latest quarterly Drug Pipeline Insights Report, OptumRx includes a diverse array of medications that the UnitedHealth Group-owned PBM believes are likely to make a market impact when they’re approved by the...
0 Comments
© 2025 MMIT

News Briefs

✦ Documents that will be reviewed by an FDA panel on Dec. 10 conclude that Pfizer Inc.’s vaccine for the novel coronavirus offers meaningful protection against the virus within 10 days of initial dosing, tipping...
0 Comments
© 2025 MMIT

Rebate Rule Rises From Dead, but Could Still Be Doomed

On Nov. 20, HHS finalized a once-tabled regulation that would revamp the Medicare prescription drug rebate system. While that may seem to be unwelcome news to the health insurers and PBMs that have vocally opposed t...
0 Comments
© 2025 MMIT

For PBMs, Amazon Pharmacy May Be Both Friend and Foe

Amazon.com, Inc. made a splash in the health care world on Nov. 17 when the online retail powerhouse unveiled new pharmacy offerings that aim to disrupt the prescription drug market with increased convenience and sa...
0 Comments
© 2025 MMIT

News Briefs

✦ Prime Therapeutics LLC, the PBM co-owned by 18 Blue Cross and Blue Shield plans, hired a new data analytics executive team. The new hires include Urvi Randhar as senior vice president and chief information and t...
0 Comments
© 2025 MMIT